Literature DB >> 2824803

Novel processing pathway for proopiomelanocortin in lymphocytes: endotoxin induction of a new prohormone-cleaving enzyme.

D V Harbour1, E M Smith, J E Blalock.   

Abstract

We have discovered that the immune system processes proopiomelanocortin (POMC) products differently depending on the stimulus for induction. We have shown that corticotropin-releasing factor (CRF) induces the lymphocytes from C3HeB/FeJ lipopolysaccharide (LPS)-sensitive mice to produce adrenocorticotropin (ACTH) 1-39 and beta-endorphin, whereas LPS induces these lymphocytes to produce ACTH 1-23 to 26 and alpha- or gamma-endorphin. We have proposed that the smaller species of ACTH and endorphin are proteolytic cleavage products from ACTH 1-39 and beta-endorphin. Analysis of C3HeB/FeJ LPS-treatment B lymphocyte lysates showed an enzymatic activity at pH 5 but not pH 7 that cleaved ACTH 1-39 into a smaller ACTH 1-23 to 26. The B lymphocytes from C3H/HeJ (LPS-resistant) mice expressed but did not process proopiomelanocortin after LPS or CRF treatment, nor did their B cells express the aforementioned enzymatic activity. Taken together, these data suggest a unique processing pathway in LPS-treated B lymphocytes and one in which immunoreactive (ir)-endorphins may play a role in the pathophysiology of endotoxic shock.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824803     DOI: 10.1002/jnr.490180116

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  β-endorphin binding in cultured adrenal cortical cells.

Authors:  R A Gelfand; A Bobrow; L Pham; C Young; L Parker
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

3.  cDNA cloning, pituitary location, and extra-pituitary expression of pro-opiomelanocortin gene in rare minnow (Gobiocypris rarus).

Authors:  Xiaohong Liu; Biwen Xie; Yaoguang Zhang; Deshou Wang; Zhijian Wang
Journal:  Fish Physiol Biochem       Date:  2010-09-29       Impact factor: 2.794

4.  Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Authors:  Jodi F Evans; Anne Fernando; Louis Ragolia
Journal:  Mol Cell Endocrinol       Date:  2012-01-27       Impact factor: 4.102

5.  Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide.

Authors:  E M Smith; F S Galin; R D LeBoeuf; D H Coppenhaver; D V Harbour; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  B Lymphocytes Express Pomc mRNA, Processing Enzymes and β-Endorphin in Painful Inflammation.

Authors:  Santhosh Chandar Maddila; Melanie Busch-Dienstfertig; Christoph Stein
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-11       Impact factor: 4.147

7.  Melanocortin receptor expression is associated with reduced CRP in response to resistance training.

Authors:  Tara M Henagan; Laura Forney; Marilyn A Dietrich; Brian R Harrell; Laura K Stewart
Journal:  J Appl Physiol (1985)       Date:  2012-06-07

8.  ACTH promotes chondrogenic nodule formation and induces transient elevations in intracellular calcium in rat bone marrow cell cultures via MC2-R signaling.

Authors:  Jodi F Evans; Sylvana Rodriguez; Louis Ragolia
Journal:  Cell Tissue Res       Date:  2013-01-29       Impact factor: 5.249

9.  Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat.

Authors:  F Gaytan; A J Martinez-Fuentes; F Garcia-Navarro; H Vaudry; E Aguilar
Journal:  Cell Tissue Res       Date:  1994-05       Impact factor: 5.249

10.  Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection.

Authors:  E M Smith; T K Hughes; F Hashemi; G B Stefano
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.